Literature DB >> 20150258

Targeted contrast-enhanced ultrasound imaging of tumor angiogenesis with contrast microbubbles conjugated to integrin-binding knottin peptides.

Jürgen K Willmann1, Richard H Kimura, Nirupama Deshpande, Amelie M Lutz, Jennifer R Cochran, Sanjiv S Gambhir.   

Abstract

UNLABELLED: Targeted contrast-enhanced ultrasound imaging is increasingly being recognized as a powerful imaging tool for the detection and quantification of tumor angiogenesis at the molecular level. The purpose of this study was to develop and test a new class of targeting ligands for targeted contrast-enhanced ultrasound imaging of tumor angiogenesis with small, conformationally constrained peptides that can be coupled to the surface of ultrasound contrast agents.
METHODS: Directed evolution was used to engineer a small, disulfide-constrained cystine knot (knottin) peptide that bound to alpha(v)beta(3) integrins with a low nanomolar affinity (Knottin(Integrin)). A targeted contrast-enhanced ultrasound imaging contrast agent was created by attaching Knottin(Integrin) to the shell of perfluorocarbon-filled microbubbles (MB-Knottin(Integrin)). A knottin peptide with a scrambled sequence was used to create control microbubbles (MB-Knottin(Scrambled)). The binding of MB-Knottin(Integrin) and MB-Knottin(Scrambled) to alpha(v)beta(3) integrin-positive cells and control cells was assessed in cell culture binding experiments and compared with that of microbubbles coupled to an anti-alpha(v)beta(3) integrin monoclonal antibody (MB(alphavbeta3)) and microbubbles coupled to the peptidomimetic agent c(RGDfK) (MB(cRGD)). The in vivo imaging signals of contrast-enhanced ultrasound with the different types of microbubbles were quantified in 42 mice bearing human ovarian adenocarcinoma xenograft tumors by use of a high-resolution 40-MHz ultrasound system.
RESULTS: MB-Knottin(Integrin) attached significantly more to alpha(v)beta(3) integrin-positive cells (1.76 +/- 0.49 [mean +/- SD] microbubbles per cell) than to control cells (0.07 +/- 0.006). Control MB-Knottin(Scrambled) adhered less to alpha(v)beta(3) integrin-positive cells (0.15 +/- 0.12) than MB-Knottin(Integrin). After blocking of integrins, the attachment of MB-Knottin(Integrin) to alpha(v)beta(3) integrin-positive cells decreased significantly. The in vivo ultrasound imaging signal was significantly higher after the administration of MB-Knottin(Integrin) than after the administration of MB(alphavbeta3) or control MB-Knottin(Scrambled). After in vivo blocking of integrin receptors, the imaging signal after the administration of MB-Knottin(Integrin) decreased significantly (by 64%). The imaging signals after the administration of MB-Knottin(Integrin) were not significantly different in the groups of tumor-bearing mice imaged with MB-Knottin(Integrin) and with MB(cRGD). Ex vivo immunofluorescence confirmed integrin expression on endothelial cells of human ovarian adenocarcinoma xenograft tumors.
CONCLUSION: Integrin-binding knottin peptides can be conjugated to the surface of microbubbles and used for in vivo targeted contrast-enhanced ultrasound imaging of tumor angiogenesis. Our results demonstrate that microbubbles conjugated to small peptide-targeting ligands provide imaging signals higher than those provided by a large antibody molecule.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20150258      PMCID: PMC4111897          DOI: 10.2967/jnumed.109.068007

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  27 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

Review 2.  Role of integrins in cell invasion and migration.

Authors:  John D Hood; David A Cheresh
Journal:  Nat Rev Cancer       Date:  2002-02       Impact factor: 60.716

Review 3.  Microbubbles in medical imaging: current applications and future directions.

Authors:  Jonathan R Lindner
Journal:  Nat Rev Drug Discov       Date:  2004-06       Impact factor: 84.694

4.  Protease inhibitors from Ecballium elaterium seeds.

Authors:  A Favel; H Mattras; M A Coletti-Previero; R Zwilling; E A Robinson; B Castro
Journal:  Int J Pept Protein Res       Date:  1989-03

Review 5.  Squash inhibitors: from structural motifs to macrocyclic knottins.

Authors:  Laurent Chiche; Annie Heitz; Jean-Christophe Gelly; Jérôme Gracy; Pham T T Chau; Phan T Ha; Jean-François Hernandez; Dung Le-Nguyen
Journal:  Curr Protein Pept Sci       Date:  2004-10       Impact factor: 3.272

6.  A novel approach for the identification of unique tumor vasculature binding peptides using an E. coli peptide display library.

Authors:  C K Brown; R A Modzelewski; C S Johnson; M K Wong
Journal:  Ann Surg Oncol       Date:  2000-12       Impact factor: 5.344

7.  Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha(v)beta3.

Authors:  Dilantha B Ellegala; Howard Leong-Poi; Joan E Carpenter; Alexander L Klibanov; Sanjiv Kaul; Mark E Shaffrey; Jiri Sklenar; Jonathan R Lindner
Journal:  Circulation       Date:  2003-06-30       Impact factor: 29.690

8.  Engineered cystine knot peptides that bind alphavbeta3, alphavbeta5, and alpha5beta1 integrins with low-nanomolar affinity.

Authors:  Richard H Kimura; Aron M Levin; Frank V Cochran; Jennifer R Cochran
Journal:  Proteins       Date:  2009-11-01

9.  Immunogenicity of a disulphide-containing neurotoxin: presentation to T-cells requires a reduction step.

Authors:  B Maillère; G Mourier; M Hervé; J Cotton; S Leroy; A Ménez
Journal:  Toxicon       Date:  1995-04       Impact factor: 3.033

10.  Microbubbles targeted to intercellular adhesion molecule-1 bind to activated coronary artery endothelial cells.

Authors:  F S Villanueva; R J Jankowski; S Klibanov; M L Pina; S M Alber; S C Watkins; G H Brandenburger; W R Wagner
Journal:  Circulation       Date:  1998-07-07       Impact factor: 29.690

View more
  63 in total

Review 1.  Contrast-enhanced ultrasound for molecular imaging of angiogenesis.

Authors:  J R Eisenbrey; F Forsberg
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-08       Impact factor: 9.236

Review 2.  Leveraging the power of ultrasound for therapeutic design and optimization.

Authors:  Charles F Caskey; Xiaowen Hu; Katherine W Ferrara
Journal:  J Control Release       Date:  2011-07-30       Impact factor: 9.776

Review 3.  Vascular targeting of nanoparticles for molecular imaging of diseased endothelium.

Authors:  Prabhani U Atukorale; Gil Covarrubias; Lisa Bauer; Efstathios Karathanasis
Journal:  Adv Drug Deliv Rev       Date:  2016-09-15       Impact factor: 15.470

4.  Ultrasound molecular imaging of tumor angiogenesis with a neuropilin-1-targeted microbubble.

Authors:  Hua Zhang; Sarah Tam; Elizabeth S Ingham; Lisa M Mahakian; Chun-Yen Lai; Spencer K Tumbale; Tambet Teesalu; Neil E Hubbard; Alexander D Borowsky; Katherine W Ferrara
Journal:  Biomaterials       Date:  2015-04-16       Impact factor: 12.479

5.  Early detection: Spotting the first signs.

Authors:  Neil Savage
Journal:  Nature       Date:  2011-03-24       Impact factor: 49.962

6.  Efficacy of Affibody-Based Ultrasound Molecular Imaging of Vascular B7-H3 for Breast Cancer Detection.

Authors:  Rakesh Bam; Patrick S Lown; Lawrence A Stern; Karina Sharma; Katheryne E Wilson; Gregory R Bean; Amelie M Lutz; Ramasamy Paulmurugan; Benjamin J Hackel; Jeremy Dahl; Lotfi Abou-Elkacem
Journal:  Clin Cancer Res       Date:  2020-01-10       Impact factor: 12.531

Review 7.  Plant cystine-knot peptides: pharmacological perspectives.

Authors:  Barbara Molesini; Davide Treggiari; Andrea Dalbeni; Pietro Minuz; Tiziana Pandolfini
Journal:  Br J Clin Pharmacol       Date:  2016-04-22       Impact factor: 4.335

8.  Volumetric contrast-enhanced ultrasound imaging to assess early response to apoptosis-inducing anti-death receptor 5 antibody therapy in a breast cancer animal model.

Authors:  Kenneth Hoyt; Anna Sorace; Reshu Saini
Journal:  J Ultrasound Med       Date:  2012-11       Impact factor: 2.153

9.  In vitro characterization and in vivo ultrasound molecular imaging of nucleolin-targeted microbubbles.

Authors:  Hua Zhang; Elizabeth S Ingham; M Karen J Gagnon; Lisa M Mahakian; Jingfei Liu; Josquin L Foiret; Juergen K Willmann; Katherine W Ferrara
Journal:  Biomaterials       Date:  2016-11-21       Impact factor: 12.479

10.  Ultrasound for molecular imaging and therapy in cancer.

Authors:  Osamu F Kaneko; Jürgen K Willmann
Journal:  Quant Imaging Med Surg       Date:  2012-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.